Nadine Schroeder nackt sorted by
relevance

Admin07.08.2021

SITC 2017 Abstract Titles

nl, Netherlands, Netherlands 3Bristol-Myers Squibb, Lawrence Township, NJ, USA 4NanoString Technologies, Seattle, WA, USA Immune contexture Immune tolerance Tumor microenvironment Biomarkers Checkpoint blockade Clinical study Immune monitoring Tumor evasion P100 Pretreatment gene expression correlation with clinical response to pembrolizumab or nivolumab in metastatic melanoma Sarah Warren 1, Patrick Danaher 1, Tobias Schatton 2 1 NanoString Technologies, Seattle, WA, USA 2Brigham-Women's Hospital, Boston, MA, USA Bioinformatics Immune contexture Immune tolerance Biomarkers Immune suppression P101 Multiplex Biomarker Detection in FFPE Tumour Samples Mike Millar 1, Louise Welch 1, Dawn Lyster 1, Mariana Beltran 1, Sevi Giakoumelou 1 1 Aquila BioMedical, Edinburgh, United Kingdom Tumor microenvironment Immune monitoring Biomarkers Immune contexture Antigen presenting cells Myeloid cells Tumor antigens B cell T cell P102 Mining the periphery for tumor-relevant B and T cells Katherine L.
1200
Admin16.08.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Baker 1, Majid Ghoddusi 1 1 Five Prime Therapeutics, Inc.
2305
Admin23.07.2021

Council

, New York, NY, USA 8St.
2101
Admin18.07.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Franz Cancer Research Center, Portland, OR, USA Biomarkers Checkpoint blockade Solid tumors P87 Results of epigenetic-based quantitative PCR assisted immune cell counting analysis in bavituximab SUNRISE trial subgroup Nikoletta L.
503
Admin23.08.2021

SITC 2017 Abstract Titles

, New Haven, CT, USA 2Alexion Pharmaceuticals, Inc.
6109
Admin13.07.2021

Council

Chiles Research Institute, Providence Cancer Center, Portland, OR, USA 3Oslo, Norway 4Oslo University Hospital Rikshospitalet, Oslo, Norway B cell Antibody Biomarkers Clinical study Immune monitoring Proteomics Tumor antigens Vaccine T cell Clinical trial P39 Use of ex vivo Histoculture to identify potential predictive biomarkers for the ICOS agonist antibody, JTX-2011 Heather Hirsch 1, Jason Reeves 1, Tong Zi 1, Amit Deshpande 1, Guang Yang 1, Alexander Needham 1, Jenny Shu 1, Christopher Harvey 1, Sriram Sathyanaryanan 1, Jennifer Michaelson 1, Emma Lees 1, Elizabeth Trehu 1, Debbie Law 1 1 Jounce Therapeutics, Inc.
4407
Admin28.07.2021

Council

Council Liaison — Kelly Jeffrey.
5206
Admin05.08.2021

Find Nadine Schroeder's Background Report in the US

Mailloux 1, Alisha Agrawal 1, Braydon J.
6809
Admin29.07.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Williams 1, Lukas Pfannenstiel 2, Eldar Giladi 1, Yvonne Leung 1, Xiaobin Tang 1, Shuwei Jiang 1, Dongkyoon Kim 1, Kevin Williamson 1, Sean M.
9909
Admin27.06.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Congregational Contact — Christa Ihrig AD HOC MINISTRY CATEGORY• , Seattle, WA, USA Regulatory T cell Treg T cell lineages Tumor microenvironment Biomarkers Tumor antigens Tumor stroma Antibody Solid tumors T cell Tumor infiltrating lymphocytes TILs P66 Digital spatial profiling platform allows both spatially-resolved, multiplexed measurement of solid tumor and immune-associated protein distribution and abundance using a single FFPE tissue section Youngmi Kim 1, Chris Merritt 1, Giang Ong 1, Kristi Barker 1, Jaemyeong Jung 1, Isaac Sprague 1, Yan Liang 1, Sarah Warren 1, Philippa Webster 1, Dwayne Dunaway 1, Joseph Beechem 1 1 NanoString Technologies Inc.
7505